Dr. Kim is a distinguished leader in the synthetic and biopharmaceutical fields, having successfully led numerous development projects, including several that resulted in global licensing deals. He has expressed strong confidence in TiumBio’s pipeline, stating that “the outlook for our three lead assets is very promising, with low chances of failure.” Dr. Kim remains committed to advancing innovative therapies for the global market, aiming to deliver meaningful benefits to patients in need.